Spero Therapeutics
SPRO
SPRO
60 hedge funds and large institutions have $93.2M invested in Spero Therapeutics in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $104M → $93.2M (-$10.8M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
60
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5.36M | |
| 2 | +$1.07M | |
| 3 | +$1.02M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$646K |
| 5 |
AG
Artal Group
Luxembourg
|
+$614K |
Top Sellers
| 1 | -$2.28M | |
| 2 | -$1.27M | |
| 3 | -$633K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$566K |
| 5 |
JPMorgan Chase & Co
New York
|
-$446K |